BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1083468)

  • 1. [Immunologic tissue damage and immunosuppression].
    Holm O
    Lakartidningen; 1976 Apr; 73(17):1624-8. PubMed ID: 1083468
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hair changes in immunosuppressive therapy].
    Kostanecki W; Mazurkiewicz W; Górkiewicz A; Zborzil J
    Z Haut Geschlechtskr; 1971 Oct; 46(19):704-8. PubMed ID: 5137252
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppression in patients with Crohn's disease and neoplasia: an ongoing clinical dilemma.
    Dasari BV; McBrearty A; Gardiner K
    Dis Colon Rectum; 2012 Sep; 55(9):1008-11. PubMed ID: 22874610
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxicity of immunosuppressive drugs in man.
    Decker JL
    Arthritis Rheum; 1973; 16(1):89-91. PubMed ID: 4734960
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive and cytotoxic chemotherapy: long-term complications.
    Schein PS; Winokur SH
    Ann Intern Med; 1975 Jan; 82(1):84-95. PubMed ID: 67817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of immunosuppressive drugs during pregnancy.
    Bermas BL; Hill JA
    Arthritis Rheum; 1995 Dec; 38(12):1722-32. PubMed ID: 8849343
    [No Abstract]   [Full Text] [Related]  

  • 7. [Benefits and risks of immunosuppression in chronic inflammatory bowel diseases].
    Rogler G
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1917-21. PubMed ID: 18785084
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
    Sandborn WJ
    Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of chronic diseases of connective tissue by cytostatic drugs].
    Deicher H; Fricke R; Kruli P
    Rev Clin Esp; 1970 Mar; 116(6):539-48. PubMed ID: 4996836
    [No Abstract]   [Full Text] [Related]  

  • 10. [Non-specific immunosuppressive methods and their problems].
    Kanoh T; Uchino H
    Nihon Rinsho; 1981 Apr; 39(4):1827-32. PubMed ID: 7031295
    [No Abstract]   [Full Text] [Related]  

  • 11. The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception.
    Nørgård B; Pedersen L; Jacobsen J; Rasmussen SN; Sørensen HT
    Aliment Pharmacol Ther; 2004 Mar; 19(6):679-85. PubMed ID: 15023170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical use of immunosuppressive drugs.
    Forbes IJ
    Med J Aust; 1973 Apr; 1(15):749-52. PubMed ID: 4707372
    [No Abstract]   [Full Text] [Related]  

  • 13. Repopulation of spleen autografts: cellular aspects after treatment with immunosuppressive drugs in rats.
    Laurentaci G
    Boll Ist Sieroter Milan; 1971; 50(6):478-87. PubMed ID: 5317452
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppressive therapy of immunoinflammatory diseases.
    Skinner MD; Schwartz RS
    Rheumatology; 1974; 5(0):1-48. PubMed ID: 4604573
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunodepressants used in immune system pathology. I. Cyclosporin, cyclophosphane, azathioprine and mercaptopurine].
    Napolov IuK; Borisov KB
    Farmakol Toksikol; 1991; 54(4):80-7. PubMed ID: 1786839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Position statement: immunomodulator therapy for inflammatory Bowel disease.
    Lavy A; Chowers Y; Odes HS; Eliakim R;
    Isr Med Assoc J; 2003 Mar; 5(3):164-9. PubMed ID: 12725133
    [No Abstract]   [Full Text] [Related]  

  • 17. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.
    Langagergaard V; Pedersen L; Gislum M; Nørgard B; Sørensen HT
    Aliment Pharmacol Ther; 2007 Jan; 25(1):73-81. PubMed ID: 17229222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunodeficiency induced by immunosuppressive agents].
    Ohashi H; Ohno R
    Ryoikibetsu Shokogun Shirizu; 2000; (32):440-3. PubMed ID: 11212769
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic polymorphism and outcomes with azathioprine and 6-mercaptopurine.
    Gardiner SJ; Begg EJ; Barclay ML; Kirkpatrick CM
    Adverse Drug React Toxicol Rev; 2000 Dec; 19(4):293-312. PubMed ID: 11212460
    [No Abstract]   [Full Text] [Related]  

  • 20. Azathioprine prescribing in neurology.
    Goldsmith P; Lennox G; Bhalla N
    J Neurol; 2008 Jun; 255(6):791-5. PubMed ID: 18481037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.